JP4503180B2 - 視覚および記憶障害のための組成物および使用法 - Google Patents

視覚および記憶障害のための組成物および使用法 Download PDF

Info

Publication number
JP4503180B2
JP4503180B2 JP2000564611A JP2000564611A JP4503180B2 JP 4503180 B2 JP4503180 B2 JP 4503180B2 JP 2000564611 A JP2000564611 A JP 2000564611A JP 2000564611 A JP2000564611 A JP 2000564611A JP 4503180 B2 JP4503180 B2 JP 4503180B2
Authority
JP
Japan
Prior art keywords
linear
alkenyl
alkyl
group
branched
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2000564611A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002522484A (ja
Inventor
ダグラス ティー． ロス、
ハンスヨルグ ザウアー、
グレゴリー エス． ハミルトン、
ジョゼフ ピー． シュタイナー、
Original Assignee
ジーピーアイ ニル ホールディングス インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ジーピーアイ ニル ホールディングス インコーポレイテッド filed Critical ジーピーアイ ニル ホールディングス インコーポレイテッド
Publication of JP2002522484A publication Critical patent/JP2002522484A/ja
Application granted granted Critical
Publication of JP4503180B2 publication Critical patent/JP4503180B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
JP2000564611A 1998-08-14 1999-08-12 視覚および記憶障害のための組成物および使用法 Expired - Fee Related JP4503180B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13442298A 1998-08-14 1998-08-14
US09/134,422 1998-08-14
PCT/US1999/018241 WO2000009108A2 (fr) 1998-08-14 1999-08-12 Compositions destinees a des troubles de la vision et de la memoire, et leurs utilisations

Publications (2)

Publication Number Publication Date
JP2002522484A JP2002522484A (ja) 2002-07-23
JP4503180B2 true JP4503180B2 (ja) 2010-07-14

Family

ID=22463332

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000564611A Expired - Fee Related JP4503180B2 (ja) 1998-08-14 1999-08-12 視覚および記憶障害のための組成物および使用法

Country Status (5)

Country Link
EP (1) EP1105112A2 (fr)
JP (1) JP4503180B2 (fr)
AU (1) AU5555699A (fr)
CA (1) CA2335815A1 (fr)
WO (1) WO2000009108A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6218424B1 (en) * 1996-09-25 2001-04-17 Gpi Nil Holdings, Inc. Heterocyclic ketone and thioester compounds and uses
CA2379993A1 (fr) * 1999-07-30 2001-02-08 Vertex Pharmaceuticals Incorporated Derives d'amines acycliques et cycliques
AR034103A1 (es) * 1999-11-12 2004-02-04 Alcon Inc Composicion farmaceutica que comprende ligandos de neurofilina para el tratamiento de condiciones oculares
CN1240691C (zh) * 2001-12-06 2006-02-08 中国人民解放军军事医学科学院毒物药物研究所 取代五元氮杂环类化合物及其预防和治疗神经退行性疾病的用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192773A (en) * 1990-07-02 1993-03-09 Vertex Pharmaceuticals, Inc. Immunosuppressive compounds
WO1992019593A1 (fr) * 1991-05-09 1992-11-12 Vertex Pharmaceuticals Incorporated Nouveaux composes immunosuppresseurs
US5696135A (en) * 1995-06-07 1997-12-09 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth
US5859031A (en) * 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
US6037370A (en) * 1995-06-08 2000-03-14 Vertex Pharmaceuticals Incorporated Methods and compositions for stimulating neurite growth
US5801197A (en) * 1995-10-31 1998-09-01 Gpi Nil Holdings, Inc. Rotamase enzyme activity inhibitors
WO1997031020A1 (fr) * 1996-02-22 1997-08-28 The General Hospital Corporation PROCEDES ET COMPOSITIONS POUR AMELIORER LA REPONSE CELLULAIRE AUX LIGANDS DE TGF-$g(b)
US5801187A (en) * 1996-09-25 1998-09-01 Gpi-Nil Holdings, Inc. Heterocyclic esters and amides
US5786378A (en) * 1996-09-25 1998-07-28 Gpi Nil Holdings, Inc. Heterocyclic thioesters
US5846979A (en) * 1997-02-28 1998-12-08 Gpi Nil Holdings, Inc. N-oxides of heterocyclic esters, amides, thioesters, and ketones
WO1998048784A2 (fr) * 1997-04-28 1998-11-05 The University Of British Columbia Methodes et composition de modulation de l'amyloidose
US6121280A (en) * 1998-03-24 2000-09-19 Pfizer Inc. Azabicyclic rotomase inhibitors

Also Published As

Publication number Publication date
WO2000009108A3 (fr) 2000-05-18
CA2335815A1 (fr) 2000-02-24
EP1105112A2 (fr) 2001-06-13
AU5555699A (en) 2000-03-06
JP2002522484A (ja) 2002-07-23
WO2000009108A2 (fr) 2000-02-24

Similar Documents

Publication Publication Date Title
US7410995B1 (en) N-linked sulfonamide of heterocyclic thioesters for vision and memory disorders
US6218423B1 (en) Pyrrolidine derivatives for vision and memory disorders
US7265150B1 (en) Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds for vision and memory disorders
JP2002522487A (ja) 視力及び記憶障害に対するヘテロサイクリックエステル又はアミド
JP4503180B2 (ja) 視覚および記憶障害のための組成物および使用法
US6384056B1 (en) Heterocyclic thioesters or ketones for vision and memory disorders
JP2002522495A (ja) 視覚障害および記憶障害のための複素環式エステル、アミド、チオエステル、またはケトンのｎ−オキシド
US6506788B1 (en) N-linked urea or carbamate of heterocyclic thioesters for vision and memory disorders
US6395758B1 (en) Small molecule carbamates or ureas for vision and memory disorders
MXPA01001649A (es) Derivados de acido pipecolico y su uso para trastornos de la vision y de la memoria.
MXPA00013031A (es) Ureas y carbamatos de acidos carboxilicos n-heterociclicos e isoesteres, para las enfermedades de la vision y la memoria.
US6337340B1 (en) Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders
MXPA01000595A (es) Sulfonamidas de molecula pequena para transtornos de la memoria y de la vision.
MXPA00013032A (en) N-linked urea or carbamate of heterocyclic thioesters for vision and memory disorders
MXPA01000196A (en) Compositions and uses for vision and memory disorders

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060803

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090901

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20091201

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20091201

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100104

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100201

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100219

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100105

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100301

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20100303

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100323

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100421

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130430

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees